REXAHN PHARMACEUTICALS INC (REXN)
Institutional ownership reported to the SEC as of Q3 2020, across 7 quarters.
6
Reporting holders
$764.0K
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $485.0K | 233,302 | 0.00% | 6q | +11.5%+$49.9K |
| VANGUARD GROUP INC | $158.0K | 75,634 | 0.00% | 6q | +37.8%+$43.4K |
| GEODE CAPITAL MANAGEMENT, LLC | $55.0K | 26,579 | 0.00% | 6q | HELD |
| WEDBUSH SECURITIES INC | $48.0K | 23,301 | 0.00% | 2q | +45.6%+$15.0K |
| BlackRock Inc. | $18.0K | 8,830 | 0.00% | 6q | HELD |
| American Portfolios Advisors | $17 | 8 | 0.00% | 6q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2020 | 6 | $764.0K | 367,654 | 0 | 3 | 0 | 0.0% |
| Q2 2020 | 7 | $898.0K | 316,685 | 1 | 1 | 2 | 0.0% |
| Q1 2020 | 8 | $523.0K | 291,916 | 2 | 1 | 2 | 0.0% |
| Q4 2019 | 7 | $520.0K | 273,753 | 1 | 3 | 0 | 0.0% |
| Q3 2019 | 7 | $422.0K | 206,423 | 1 | 2 | 1 | 0.0% |
| Q2 2019 | 12 | $1.0M | 180,050 | 12 | 0 | 0 | 7.3% |
| Q4 2018 | 1 | $7.0K | 0 | 0 | 0 | 0 | 100.0% |